Doctors have a new concern when it comes to the popular weight loss drugs.
Weight loss drugs like Wegovy are giving doctors a new reason for concern. The new wave of popular weight loss drugs have helped many Americans cut inches of their waistlines, but that doesn’t always come without side effects and now doctors are sounding a new alarm.“They start using this drug and next thing you know, they’ve developed what looks very much like anorexia nervosa,” psychologist Tom Hildebrandt of Mount Sinai’s Center of Excellence in Eating and Weight Disorders told NBC.
The report said that the drugs, which mimic glucagon-like peptide 1, a naturally occurring hormone in the gut which controls blood sugar and can lessen hunger, have resulted in some taking the highest doses to lose as much as 21% of their body weight.24 country music artists, influencers have died in 2024. Here is who we lostPer Hildebrandt, that level of weight loss can lead the brain to believe the body is suffering from starvation.
NBC spoke to Eli Lilly, which makes Mounjaro, and the company said that patient safety is its top priority and that it actively engages “in monitoring, evaluating, and reporting safety information for all our medicines.” “If someone is experiencing any side effects while taking any Lilly medication, we encourage them to speak with their healthcare provider,” the company added.If you purchase a product or register for an account through a link on our site, we may receive compensation.
Wegovy Ozempic Weight-Loss-Drugs
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding ConditionTrendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns.
Lire la suite »
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Lire la suite »
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Lire la suite »
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years LaterThree of four patients stop taking Ozempic or Wegovy two years after being prescribed the blockbuster drugs for weight loss, a new analysis shows.
Lire la suite »
Most Patients Stop Using Wegovy, Ozempic for Weight Loss Within Two Years, Analysis FindsOnly one in four U.S. patients prescribed Novo Nordisk’s Wegovy or Ozempic for weight loss were still taking the popular medications two years later, according to an...
Lire la suite »
No More Nausea: New Discovery Could Reduce the Side Effects of Ozempic and WegovyScience, Space and Technology News 2024
Lire la suite »